☆ 4.6 Editorial Material

MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma

NEURO-ONCOLOGY (2020)

Get Full Text
Add to Collection

Journal

NEURO-ONCOLOGY
Volume 22, Issue 11, Pages 1553-1554

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/noaa212

Keywords

glioma; IDH1 mutation; temozolomide

Categories

Oncology Clinical Neurology

Funding

  1. NIH [R01CA227821, P50CA165962]
  2. Loglio Foundation
  3. Richard B. Simches Scholars Award
  4. Seeman Family MGH Scholar in Neuro-Oncology Award
  5. Tawingo Fund

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.